PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 22 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Used as a laxative and purgative to facilitate bowel movements [PMID:39755184, PMID:12570768]
Jalapinoside reversed multidrug resistance in vinblastine-resistant human breast carcinoma cells [PMID:25536852]; Purgin II inhibited multidrug efflux pumps [PMID:23273047]
Evidence summary
PubMed sources
- 1.PMID: 12570768 (2003) — Biodynamic constituents in the Mexican morning glories: purgative remedies transcending boundaries. · Current topics in medicinal chemistry
- 2.PMID: 21446661 (2011) — Resin glycosides from the herbal drug jalap (Ipomoea purga). · Journal of natural products
- 3.PMID: 39755184 (2025) — The jalap roots: A herbal legacy from the neotropics to the world. · Journal of ethnopharmacology
- 4.PMID: 27391476 (2016) — Cytotoxic potential of selected medicinal plants in northeast Brazil. · BMC complementary and alternative medicine
- 5.PMID: 25536852 (2015) — Jalapinoside, a macrocyclic bisdesmoside from the resin glycosides of Ipomea purga, as a modulator of multidrug resistance in human cancer cells.